QUEST DIAGNOSTICS INC is 6.0x more valuable than VERACYTE, INC. by market capitalization ($22.48 B vs $3.78 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCYT | DGX |
|---|---|---|
| Market cap | $3.78 B | $22.48 B |
| US-listed rank | #1633 | #582 |
| Revenue (latest FY) | $517.14M | $11.04B |
| Net income (latest FY) | $66.40M | $992.00M |
| Net margin | 12.8% | 9.0% |
| P/E (trailing FY) | 56.9 | 22.7 |
| SEC filings | 1,126 | 2,372 |
QUEST DIAGNOSTICS INC is 6.0x more valuable than VERACYTE, INC. by market capitalization ($22.48 B vs $3.78 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while QUEST DIAGNOSTICS INC reported $11.04B.
Full pages: VERACYTE, INC. and QUEST DIAGNOSTICS INC, or browse the full rankings.